Annual EBITDA
-$141.15 M
-$35.34 M-33.40%
December 31, 2024
Summary
- As of March 10, 2025, SAVA annual EBITDA is -$141.15 million, with the most recent change of -$35.34 million (-33.40%) on December 31, 2024.
- During the last 3 years, SAVA annual EBITDA has fallen by -$108.81 million (-336.53%).
- SAVA annual EBITDA is now -550.01% below its all-time high of $31.36 million, reached on December 31, 2013.
Performance
SAVA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$30.06 M
+$305.00 K+1.00%
December 31, 2024
Summary
- As of March 10, 2025, SAVA quarterly EBITDA is -$30.06 million, with the most recent change of +$305.00 thousand (+1.00%) on December 31, 2024.
- Over the past year, SAVA quarterly EBITDA has stayed the same.
- SAVA quarterly EBITDA is now -191.36% below its all-time high of $32.90 million, reached on December 31, 2013.
Performance
SAVA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$141.15 M
-$6.25 M-4.63%
December 31, 2024
Summary
- As of March 10, 2025, SAVA TTM EBITDA is -$141.15 million, with the most recent change of -$6.25 million (-4.63%) on December 31, 2024.
- Over the past year, SAVA TTM EBITDA has stayed the same.
- SAVA TTM EBITDA is now -550.01% below its all-time high of $31.36 million, reached on December 31, 2013.
Performance
SAVA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SAVA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.4% | 0.0% | 0.0% |
| 3 y3 years | -336.5% | 0.0% | 0.0% |
| 5 y5 years | -2779.9% | 0.0% | 0.0% |
SAVA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -336.5% | at low | -112.7% | +50.8% | -336.5% | at low |
| 5 y | 5-year | -2779.9% | at low | -2198.1% | +50.8% | -2855.9% | at low |
| alltime | all time | -550.0% | at low | -191.4% | +50.8% | -550.0% | at low |
Cassava Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$141.15 M(+33.4%) | -$30.06 M(-1.0%) | -$141.15 M(+4.6%) |
| Sep 2024 | - | -$30.36 M(-50.3%) | -$134.90 M(+2.2%) |
| Jun 2024 | - | -$61.10 M(+211.4%) | -$132.02 M(+32.9%) |
| Mar 2024 | - | -$19.62 M(-17.6%) | -$99.31 M(-6.1%) |
| Dec 2023 | -$105.80 M(+32.0%) | -$23.81 M(-13.4%) | -$105.80 M(+1.7%) |
| Sep 2023 | - | -$27.49 M(-3.2%) | -$104.00 M(+6.6%) |
| Jun 2023 | - | -$28.39 M(+8.7%) | -$97.56 M(+9.9%) |
| Mar 2023 | - | -$26.12 M(+18.7%) | -$88.79 M(+10.7%) |
| Dec 2022 | -$80.18 M(+148.0%) | -$22.01 M(+4.6%) | -$80.18 M(+10.9%) |
| Sep 2022 | - | -$21.05 M(+7.3%) | -$72.30 M(+18.9%) |
| Jun 2022 | - | -$19.62 M(+12.1%) | -$60.80 M(+31.3%) |
| Mar 2022 | - | -$17.51 M(+23.9%) | -$46.31 M(+43.2%) |
| Dec 2021 | -$32.33 M(+377.6%) | -$14.13 M(+48.1%) | -$32.33 M(+55.3%) |
| Sep 2021 | - | -$9.54 M(+86.0%) | -$20.83 M(+63.7%) |
| Jun 2021 | - | -$5.13 M(+45.2%) | -$12.72 M(+41.4%) |
| Mar 2021 | - | -$3.53 M(+34.7%) | -$8.99 M(+32.9%) |
| Dec 2020 | -$6.77 M(+38.1%) | -$2.62 M(+82.7%) | -$6.77 M(+18.6%) |
| Sep 2020 | - | -$1.44 M(+2.4%) | -$5.71 M(+13.3%) |
| Jun 2020 | - | -$1.40 M(+7.3%) | -$5.04 M(+5.5%) |
| Mar 2020 | - | -$1.31 M(-16.3%) | -$4.78 M(-2.6%) |
| Dec 2019 | -$4.90 M(-25.7%) | -$1.56 M(+104.2%) | -$4.90 M(+20.4%) |
| Sep 2019 | - | -$765.00 K(-32.9%) | -$4.07 M(-11.0%) |
| Jun 2019 | - | -$1.14 M(-20.5%) | -$4.57 M(-22.2%) |
| Mar 2019 | - | -$1.43 M(+95.6%) | -$5.88 M(-10.9%) |
| Dec 2018 | -$6.59 M(-44.5%) | -$733.00 K(-42.1%) | -$6.59 M(-20.2%) |
| Sep 2018 | - | -$1.27 M(-48.2%) | -$8.27 M(-13.7%) |
| Jun 2018 | - | -$2.44 M(+13.7%) | -$9.58 M(-15.1%) |
| Mar 2018 | - | -$2.15 M(-10.6%) | -$11.29 M(-5.0%) |
| Dec 2017 | -$11.88 M(-20.3%) | -$2.41 M(-6.7%) | -$11.88 M(-1.0%) |
| Sep 2017 | - | -$2.58 M(-37.9%) | -$12.00 M(-7.3%) |
| Jun 2017 | - | -$4.15 M(+51.1%) | -$12.95 M(+9.5%) |
| Mar 2017 | - | -$2.75 M(+8.7%) | -$11.83 M(-20.6%) |
| Dec 2016 | -$14.90 M(+5.2%) | -$2.53 M(-28.4%) | -$14.90 M(-11.8%) |
| Sep 2016 | - | -$3.53 M(+16.4%) | -$16.89 M(-0.8%) |
| Jun 2016 | - | -$3.03 M(-47.9%) | -$17.04 M(-2.0%) |
| Mar 2016 | - | -$5.82 M(+28.6%) | -$17.38 M(+22.8%) |
| Dec 2015 | -$14.16 M(+14.0%) | -$4.52 M(+23.1%) | -$14.16 M(+20.0%) |
| Sep 2015 | - | -$3.67 M(+8.9%) | -$11.80 M(+1.1%) |
| Jun 2015 | - | -$3.37 M(+30.2%) | -$11.67 M(+1.0%) |
| Mar 2015 | - | -$2.59 M(+19.8%) | -$11.55 M(-7.0%) |
| Dec 2014 | -$12.42 M(-139.6%) | -$2.16 M(-39.0%) | -$12.42 M(-154.8%) |
| Sep 2014 | - | -$3.54 M(+8.9%) | $22.65 M(-10.9%) |
| Jun 2014 | - | -$3.25 M(-6.0%) | $25.41 M(-10.4%) |
| Mar 2014 | - | -$3.46 M(-110.5%) | $28.35 M(-9.6%) |
| Dec 2013 | $31.36 M(-930.9%) | $32.90 M(-4340.1%) | $31.36 M(-1028.5%) |
| Sep 2013 | - | -$776.00 K(+143.3%) | -$3.38 M(-19.7%) |
| Jun 2013 | - | -$319.00 K(-28.0%) | -$4.21 M(+2.5%) |
| Mar 2013 | - | -$443.00 K(-75.9%) | -$4.10 M(+8.7%) |
| Dec 2012 | -$3.77 M | -$1.84 M(+14.8%) | -$3.77 M(+52.0%) |
| Sep 2012 | - | -$1.60 M(+635.3%) | -$2.48 M(+32.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | -$218.00 K(+92.9%) | -$1.87 M(-38.5%) |
| Mar 2012 | - | -$113.00 K(-79.4%) | -$3.04 M(-9.3%) |
| Dec 2011 | -$3.35 M(-75.1%) | -$549.00 K(-44.4%) | -$3.35 M(-72.7%) |
| Sep 2011 | - | -$988.00 K(-28.8%) | -$12.26 M(-4.1%) |
| Jun 2011 | - | -$1.39 M(+225.8%) | -$12.78 M(+1.5%) |
| Mar 2011 | - | -$426.00 K(-95.5%) | -$12.59 M(-6.5%) |
| Dec 2010 | -$13.47 M(+107.3%) | -$9.46 M(+524.6%) | -$13.47 M(+139.7%) |
| Sep 2010 | - | -$1.51 M(+26.6%) | -$5.62 M(-11.2%) |
| Jun 2010 | - | -$1.20 M(-8.3%) | -$6.33 M(+18.7%) |
| Mar 2010 | - | -$1.30 M(-18.8%) | -$5.33 M(-17.9%) |
| Dec 2009 | -$6.50 M(-170.9%) | -$1.60 M(-27.9%) | -$6.50 M(-15.2%) |
| Sep 2009 | - | -$2.23 M(+1007.0%) | -$7.66 M(-190.2%) |
| Jun 2009 | - | -$201.00 K(-91.8%) | $8.49 M(+36.0%) |
| Mar 2009 | - | -$2.47 M(-11.0%) | $6.25 M(-31.8%) |
| Dec 2008 | $9.16 M(-12.9%) | -$2.77 M(-119.9%) | $9.16 M(-11.9%) |
| Sep 2008 | - | $13.93 M(-669.3%) | $10.40 M(+2.1%) |
| Jun 2008 | - | -$2.45 M(-640.2%) | $10.18 M(-24.8%) |
| Mar 2008 | - | $453.00 K(-129.5%) | $13.55 M(-42.2%) |
| Dec 2007 | $10.53 M(-2003.3%) | -$1.54 M(-111.2%) | $23.45 M(+45.9%) |
| Sep 2007 | - | $13.71 M(+1392.3%) | $16.07 M(-26.6%) |
| Jun 2007 | - | $919.00 K(-91.1%) | $21.90 M(-2.6%) |
| Mar 2007 | - | $10.36 M(-216.2%) | $22.49 M(+78.0%) |
| Dec 2006 | -$553.00 K(-98.3%) | -$8.92 M(-145.6%) | $12.63 M(-29.8%) |
| Sep 2006 | - | $19.54 M(+1194.8%) | $17.99 M(-268.1%) |
| Jun 2006 | - | $1.51 M(+200.6%) | -$10.71 M(-53.0%) |
| Mar 2006 | - | $502.00 K(-114.1%) | -$22.78 M(-29.6%) |
| Dec 2005 | -$32.35 M(-16.1%) | -$3.56 M(-61.2%) | -$32.35 M(-16.0%) |
| Sep 2005 | - | -$9.16 M(-13.3%) | -$38.52 M(-0.4%) |
| Jun 2005 | - | -$10.57 M(+16.5%) | -$38.67 M(+3.7%) |
| Mar 2005 | - | -$9.07 M(-6.8%) | -$37.30 M(-3.3%) |
| Dec 2004 | -$38.58 M(+76.1%) | -$9.73 M(+4.6%) | -$38.58 M(+8.1%) |
| Sep 2004 | - | -$9.31 M(+1.3%) | -$35.70 M(+10.2%) |
| Jun 2004 | - | -$9.19 M(-11.2%) | -$32.40 M(+17.4%) |
| Mar 2004 | - | -$10.35 M(+51.1%) | -$27.58 M(+25.9%) |
| Dec 2003 | -$21.91 M(-226.9%) | -$6.85 M(+14.0%) | -$21.91 M(-262.9%) |
| Sep 2003 | - | -$6.01 M(+37.2%) | $13.45 M(-16.8%) |
| Jun 2003 | - | -$4.38 M(-6.3%) | $16.17 M(-34.8%) |
| Mar 2003 | - | -$4.67 M(-116.4%) | $24.81 M(-3.1%) |
| Dec 2002 | $17.27 M(-208.8%) | $28.51 M(-966.8%) | $25.59 M(-430.5%) |
| Sep 2002 | - | -$3.29 M(-177.2%) | -$7.74 M(-3.0%) |
| Jun 2002 | - | $4.26 M(-209.5%) | -$7.98 M(-50.6%) |
| Mar 2002 | - | -$3.89 M(-19.3%) | -$16.16 M(+3.9%) |
| Dec 2001 | -$15.87 M(+12.2%) | -$4.82 M(+36.6%) | -$15.56 M(+4.4%) |
| Sep 2001 | - | -$3.53 M(-10.0%) | -$14.90 M(+4.3%) |
| Jun 2001 | - | -$3.92 M(+19.2%) | -$14.29 M(+25.4%) |
| Mar 2001 | - | -$3.29 M(-21.0%) | -$11.40 M(+38.8%) |
| Dec 2000 | -$14.15 M(+353.4%) | -$4.16 M(+42.6%) | -$8.21 M(+102.9%) |
| Sep 2000 | - | -$2.92 M(+184.2%) | -$4.05 M(+258.9%) |
| Jun 2000 | - | -$1.03 M(+921.2%) | -$1.13 M(+1021.2%) |
| Mar 2000 | - | -$100.60 K | -$100.60 K |
| Dec 1999 | -$3.12 M | - | - |
FAQ
- What is Cassava Sciences annual EBITDA?
- What is the all time high annual EBITDA for Cassava Sciences?
- What is Cassava Sciences annual EBITDA year-on-year change?
- What is Cassava Sciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cassava Sciences?
- What is Cassava Sciences quarterly EBITDA year-on-year change?
- What is Cassava Sciences TTM EBITDA?
- What is the all time high TTM EBITDA for Cassava Sciences?
- What is Cassava Sciences TTM EBITDA year-on-year change?
What is Cassava Sciences annual EBITDA?
The current annual EBITDA of SAVA is -$141.15 M
What is the all time high annual EBITDA for Cassava Sciences?
Cassava Sciences all-time high annual EBITDA is $31.36 M
What is Cassava Sciences annual EBITDA year-on-year change?
Over the past year, SAVA annual EBITDA has changed by -$35.34 M (-33.40%)
What is Cassava Sciences quarterly EBITDA?
The current quarterly EBITDA of SAVA is -$30.06 M
What is the all time high quarterly EBITDA for Cassava Sciences?
Cassava Sciences all-time high quarterly EBITDA is $32.90 M
What is Cassava Sciences quarterly EBITDA year-on-year change?
Over the past year, SAVA quarterly EBITDA has changed by $0.00 (0.00%)
What is Cassava Sciences TTM EBITDA?
The current TTM EBITDA of SAVA is -$141.15 M
What is the all time high TTM EBITDA for Cassava Sciences?
Cassava Sciences all-time high TTM EBITDA is $31.36 M
What is Cassava Sciences TTM EBITDA year-on-year change?
Over the past year, SAVA TTM EBITDA has changed by $0.00 (0.00%)